Saeed Moshashaee

Person

San Rafael, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Targeted therapeutic lysosomal enzyme fusion proteins, associated f...
- Patent number 11,345,904
- Issue date May 31, 2022
- Biomarin Pharmaceutical Inc.
- Saeed Moshashaee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 11,229,687
- Issue date Jan 25, 2022
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,758,598
- Issue date Sep 1, 2020
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,279,015
- Issue date May 7, 2019
- Biomarin Pharmaceutical Inc.
- Thomas W. Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AN...
- Publication number 20240408240
- Publication date Dec 12, 2024
- BioMarin Pharmaceutical Inc.
- Peter COLOSI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins, Associated F...
- Publication number 20240263160
- Publication date Aug 8, 2024
- BIOMARIN PHAMACEUTICAL INC.
- Saeed Moshashaee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED F...
- Publication number 20220251526
- Publication date Aug 11, 2022
- BioMarin Pharmaceutical Inc.
- SAEED MOSHASHAEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20200353059
- Publication date Nov 12, 2020
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED F...
- Publication number 20200297821
- Publication date Sep 24, 2020
- BioMarin Pharmaceutical Inc.
- SAEED MOSHASHAEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20190216905
- Publication date Jul 18, 2019
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE
- Publication number 20160324942
- Publication date Nov 10, 2016
- BioMarin Pharmaceutical Inc.
- Thomas W. Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Saeed Moshashaee

Person

Patents Grantslast 30 patents

Targeted therapeutic lysosomal enzyme fusion proteins, associated f...

TPP-1 formulations and methods for treating CLN2 disease

TPP-1 formulations and methods for treating CLN2 disease

TPP-1 formulations and methods for treating CLN2 disease

Patents Applicationslast 30 patents

TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AN...

Targeted Therapeutic Lysosomal Enzyme Fusion Proteins, Associated F...

TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED F...

TPP-1 Formulations and Methods for Treating CLN2 Disease

TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS, ASSOCIATED F...

TPP-1 Formulations and Methods for Treating CLN2 Disease

TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE